Landlord demands EMA pay £500m for Canary Wharf lease
July 27, 2018Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court
A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …
Cannabis-derived medicinal products to become available in UK
July 26, 2018Medical Communications cannabis, law, medicinal marijuana, prescription, sajid javid, schedule drugs, uk politics
Home Secretary Sajid Javid has announced that cannabis derived medicinal products will be made available on prescription “by the autumn” …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
Merck KGaA announces new Senior Vice President, Head of Global Affairs
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development
Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Gilead’s CEO and Chairman to both step down before year’s end
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
AstraZeneca announces price freezes while earnings drop by 28%
July 26, 2018Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes
The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …
Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials
July 26, 2018Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research
An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …
NHS to stockpile drugs in preparation for no-deal Brexit
July 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling
Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
FDA approves first endometriosis pain management drug in a decade
July 25, 2018Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma
The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
HPV vaccine to be given to boys in England
July 25, 2018Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus
The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …
Pfizer to build $465m sterile injectable plant in Michigan
July 25, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma
Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
More antidepressants being prescribed to children in UK
July 25, 2018Research and Development antidepressants, children, mental health, prescription, young people
Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …
Eleven babies dead after Dutch viagra trial
July 25, 2018Research and Development Netherlands, clinical trial, deaths, premature, viagra
A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …
Teva Romania announces new general manager
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
Bristol Myers Squibb announces departure of Chief Commercial Officer
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, bristol myers squibb, commerical executive, marketing, sales
Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …
Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma
July 24, 2018Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma
Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …
Employees protest against shutting down of GSK facility in Bangladesh
July 24, 2018Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union
Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …
Scientists launch free, open access, antibiotics database to tackle AMR
July 24, 2018Manufacturing and Production AMR, Antibiotics, Database, academia, resistance
A team of scientists, led by Professor Laura Piddock from the University of Birmingham, have launched a free, open access, …
AstraZeneca jettisons European heart drug rights for $210m
July 24, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma
AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …
First new treatment for reccurent malaria approved in over 60 years
July 23, 2018Manufacturing and Production FDA, GSK, approval, malaria, p.vivax
The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
